Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

PD-098059 inhibits AII-induced MAPK activation in myocardial cells

May 28, 1999

Electrophysiological assessment of the sodium channel-blocking activity of RSD-921

May 26, 1999

Dietary omega-3 fatty acids have mild effect on coronary atherosclerosis

May 26, 1999

Transplantation news: neutrophil NADPH oxidase inhibitor improves functioning of preserved hearts

May 25, 1999

BASF describes new, selective ECE inhibitors

May 25, 1999

Glaxo Wellcome launches first drug to treat PPH in Japan

May 25, 1999

MediGene discovers target gene for DCM therapy

May 24, 1999

Warner-Lambert presents new MMP inhibitors and their use

May 20, 1999

FDA allows LXR Biotechnology's IND for CP-Cardiosol

May 20, 1999

Avalide now available in U.S. for hypertension

May 20, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...